CD40LG and COVID-19: In the present study, ELISA demonstrated that the IgM reactivity peak was obtained during the first two weeks after symptom onset, whereas the IgG reactivity peak was observed around the fifth or sixth week after symptom onset in the COVID-19 cohort (Figure 1A).